A brief introduction to research based on real-world evidence: Considering the Korean National Health Insurance Service database

A brief introduction to research based on real-world evidence: Considering the Korean National Health Insurance Service database

Saved in:

Bibliographic Details
Main Author:	Eun Kyoung Ahn
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	Integrative Medicine Research
Subjects:	Real-world data Real-world evidence National health insurance service database
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213422021000846
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Review of data sources used in real-world traumatology and orthopedic
by: I. U. Zolotukhina, et al.
Published: (2023-12-01)

Educational pharmacoepidemiology and "Real-World Knowledge"
by: R. A. Bontsevich
Published: (2025-01-01)

Research on Application of Medical Device Real-World Evidence in Regulatory Decisions of the United States
by: Xiaofang GU, et al.
Published: (2025-07-01)

Real-world data analysis on effectiveness of integrative therapies: A practical guide to study design and data analysis using healthcare databases
by: Ye-Seul Lee, et al.
Published: (2023-12-01)

Real-World Evidence and Managed Entry Agreements
by: Silvia Adami, et al.
Published: (2025-07-01)

Real-world evidence market: key players and key segments
by: A. R. Kasimova, et al.
Published: (2022-01-01)

Use of real-world data as pivotal evidence in veterinary regulatory applications
by: Raffaele Bruno
Published: (2025-06-01)

Resolution based on the results of the III annual scientific and practical conference «Real clinical practice in a changing world. Challenges and Solutions»
by: A. S. Kolbin
Published: (2022-11-01)

A brief report of real-world evidence development (RWD/RWE) in 2021: United States, Russia, and the Eurasian Economic Union (EAEU)
by: A. S. Kolbin, et al.
Published: (2022-01-01)

ICH Reflection paper on proposed international harmonization of real-world evidence terminology and convergence of general principles regarding planning and reporting of studies using real-world data, with a focus on effectiveness of drugs
by: K. S. Radaeva, et al.
Published: (2023-10-01)

Redefining comorbidity understanding in rheumatoid arthritis through novel approaches using real-world data
by: Diego Benavent, et al.
Published: (2024-02-01)

Resolution based on the results of the conference: "RWD/ RWE – Research Tools of Real-World Clinical Practice Today and Tomorrow"
by: A. S. Kolbin
Published: (2021-08-01)

Real-world data studies in oncology: analysis of the Russian publications
by: V. F. Achikyan, et al.
Published: (2024-04-01)

Resolution based on the results of the IV annual scientific-practical conference "Real clinical practice. Modernity and the future"
by: A. S. Kolbin
Published: (2023-12-01)

Herbal medicine evaluation for reimbursement-based facial palsy (HERB-FP): a retrospective analysis using Korean health insurance claim data 2020–2024
by: Soo-Dam Kim, et al.
Published: (2025-08-01)

DARWIN EU® is an electronic platform for the collection and analysis of health data in the European Union
by: K. S. Radaeva, et al.
Published: (2023-01-01)

Real-world treatment patterns and outcomes for patients with non-metastatic non-small cell lung cancer: retrospective analyses in Canada, England, and Germany
by: Alastair Greystoke, et al.
Published: (2025-05-01)

REAL WORLD EVIDENCE AND BIG DATA
by: Mehmet Güven Günver
Published: (2022-08-01)

Real‐world evidence of brigatinib as second‐line treatment after crizotinib for ALK+ non‐small cell lung cancer using South Korean claims data (K‐AREAL)
by: Jeong Eun Lee, et al.
Published: (2024-07-01)

Current and future perspective of registry utilisation for regulatory settings in Japan: pharmaceuticals, medical devices, and regenerative medicine products
by: Chieko Ishiguro, et al.
Published: (2025-12-01)

An overview of real-world study in clinical transfusion
by: GONG Jiashun, et al.
Published: (2025-07-01)

HARPER — protocol template for real-world trials for evaluating treatment efficacy
by: S. M. Mukhina, et al.
Published: (2023-01-01)

Resolution based on the results of the V annual scientific-practical conference "RWD/RWE. Possible and real"
by: A. S. Kolbin, et al.
Published: (2024-12-01)

Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015–2019)
by: Dionysios Neofytos, et al.
Published: (2024-10-01)

The role of real world data and real world evidence in health technology assessment
by: E. A. Novoderezhkina, et al.
Published: (2022-10-01)

Real-World Evidence for Comparative Outcomes between Innovator and Biosimilar Bevacizumab in Advanced Colorectal Cancers
by: Arvind Vaidyanathan, et al.
Published: (2024-10-01)

Real-World Comparison of Trifluridine–Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer
by: Hyunho Kim, et al.
Published: (2025-04-01)

Weight loss with real-world doravirine use in the OPERA cohort: a US-based cohort study
by: Karam Mounzer, et al.
Published: (2025-06-01)

Peculiarities of real-world data application for health technology assessment in Asian countries
by: B. B. Kondratyeva, et al.
Published: (2024-02-01)

Real-World Treatment Patterns, Clinical Outcomes, and Costs in Patients with Higher-Risk Myelodysplastic Syndromes Across France, Germany, and the United Kingdom
by: Drummond M, et al.
Published: (2025-06-01)

Crossing borders: the need for empirical evidence of real-world evidence transportability in oncology
by: Caitlin Clunie-O’Connor, et al.
Published: (2025-07-01)

Legal particularities of AI technology usage in real-world data formation
by: V. S. Malichenko, et al.
Published: (2024-02-01)

Requirements and Technical Aspects of Real world Data Governance in China's Medical Standards and Specifications
by: GUAN Xinmiao, et al.
Published: (2024-09-01)

Comparison of outcomes with elranatamab and real world treatments in the UK for triple class exposed relapsed and refractory multiple myeloma
by: Carmen Tsang, et al.
Published: (2025-07-01)

Real-world evidence of biological treatments in rheumatoid arthritis and spondyloarthritis in Morocco: results of the RBSMR registry
by: Najlae El Ouardi, et al.
Published: (2025-05-01)

Tirzepatide safety in type 2 diabetes: a disproportionality analysis of adverse events using the FDA FAERS database
by: Zhenpo Zhang, et al.
Published: (2025-07-01)

Use of olokizumab, a direct interleukin 6 inhibitor, in the treatment of rheumatoid arthritis: real-world evidence
by: P. A. Shesternya, et al.
Published: (2025-04-01)

Indirect Comparison Between Bimekizumab and Brodalumab for the Management of Moderate to Severe Psoriasis: A 36-Week Real-Life Study
by: Luca Potestio, et al.
Published: (2025-02-01)

Real‑World Experience of 1 Year of Tralokinumab Treatment in Adult Patients with Atopic Dermatitis: A Single-Center Retrospective Study
by: Adrian O. Rodriguez, et al.
Published: (2025-06-01)

Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology Network
by: Cosgrove D, et al.
Published: (2025-04-01)